BriaCell Therapeutics CorpCompany Review & Valuation

BCTXF
OTC Markets
Latest Price
3.53USD

About BriaCell Therapeutics Corp

BriaCell Therapeutics Corp., an immuno-oncology focused biotechnology company, engages in developing approaches for the management of cancer. Its lead product candidate is Bria-IMT that is in Phase I/IIA clinical trial for the patients with advanced breast cancer. The trial was being conducted with Show more the co-development of BriaDX, a companion diagnostic test. The company is also conducting a combination study of Bria-IMT with pembrolizumab or ipilimumab for patients with advanced breast cancer. In addition, it is developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced stage breast cancer. Further, the company has preclinical small molecule program that consists of various selective protein kinase C delta inhibitors for cancer and fibrotic diseases. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada. Show less

Industry
Biotechnology
HQ Location
West Vancouver, Canada

Stock Price

Price data not available for BriaCell Therapeutics Corp.

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top